Clinical Trials Browser

Testicular Germ Cell Tumor, Carcinoma, Ovarian Epithelial, Bile Duct Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Gallbladder Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Colorectal Neoplasms, Endodermal Sinus Tumor, Carcinoma, Medullary, Breast Neoplasms, Male, Small Cell Lung Carcinoma, Inflammatory Breast Neoplasms

NCT00005798 2012-10-26

CTC

Phase 2 Completed

209 enrolled

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00005800 2012-09-25

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

Phase 2 Completed

45 enrolled

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00005822 2010-06-11

SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

Phase 1 Completed

21 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

Clinical Trials

Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer

Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer

Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer

Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer

Olaparib and Radiotherapy in Inoperable Breast Cancer

PEGASE07

GeparX

GeparSepto

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

TKI258 for Metastatic Inflammatory Breast Cancer Patients

MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer

Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer

MUC1 Vaccine for Triple-negative Breast Cancer

NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer

NRR

Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

SHPD001

Biomarkers in Native American Women With Breast Cancer

GeparSixto

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

Biological Therapy in Treating Patients With Metastatic Cancer

CTC

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer